TY  - JOUR
AU  - Shulman, David S
AU  - Whittle, Sarah B
AU  - Surdez, Didier
AU  - Bailey, Kelly M
AU  - de-Alava, Enrique
AU  - Yustein, Jason T
AU  - Shlien, Adam
AU  - Hayashi, Masanori
AU  - Bishop, Alexander J R
AU  - Crompton, Brian D
AU  - DuBois, Steven G
AU  - Shukla, Neerav
AU  - Leavey, Patrick J
AU  - Lessnick, Stephen L
AU  - Kovar, Heinrich
AU  - Delattre, Olivier
AU  - Grünewald, Thomas G P
AU  - Antonescu, Cristina R
AU  - Roberts, Ryan D
AU  - Toretsky, Jeffrey A
AU  - Tirode, Franck
AU  - Gorlick, Richard
AU  - Janeway, Katherine A
AU  - Reed, Damon
AU  - Lawlor, Elizabeth R
AU  - Grohar, Patrick J
PY  - 2022
DO  - 10.1038/s41698-022-00307-2
SN  - 2397-768X
UR  - http://hdl.handle.net/10668/19633
T2  - NPJ precision oncology
AB  - The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60-80% of patients with...
LA  - en
PB  - Nature Publishing Group
KW  - Cancer genetics
KW  - Molecular medicine
KW  - Prognostic markers
KW  - Sarcoma
KW  - Humans
KW  - Prognosis
KW  - Circulating Tumor DNA
KW  - Sarcoma, Ewing
KW  - DNA Copy Number Variations
KW  - Loss of Function Mutation
KW  - Progression-Free Survival
KW  - Disease Progression
TI  - An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
TY  - research article
VL  - 6
ER  -